Effect of dapagliflozin on bone metabolism in patients with type 2 diabetes
Not Applicable
Recruiting
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000032220
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with severe endocrine or metabolic disorders including diabetes ketoacidosis, BMI over 45, post bariatric and metabolic surgery. The patients who have severe liver or cardiovascular disorder, malignant tumor, skeletal diseases. female patients with pregnant or brest-feeding. The patients treated with anti-osteoporosis drugs, gulcocorticoid or diuretics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method